Sign Up Today and Learn More About Strata Oncology Stock
Invest in or calculate the value of your shares in Strata Oncology or other pre-IPO companies through EquityZen's platform.
Strata Oncology Stock (STON)
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
About Strata Oncology Stock
Founded
2016
Headquarters
Ann Arbor, MI, US
Industries
Software, Artificial Intelligence, Data and Analytics
Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval. Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.
Strata Oncology Press Mentions
Stay in the know about the latest news on Strata Oncology
Methods of determining cancer therapy effectiveness
patents • Apr 02, 2025
Methods of determining cancer therapy effectiveness
patents • Feb 08, 2025
Cancer biomarkers for immune checkpoint inhibitors
patents • Feb 08, 2025
Methods of detecting ntrk fusion proteins
patents • Feb 08, 2025
Methods for identifying mutations using machine learning
patents • Feb 08, 2025
Investors in Strata Oncology
Discover investors in Strata Oncology stock and explore their portfolio companies
Strata Oncology Management
Leadership team at Strata Oncology
Co-founder & CEO
Dan Rhodes
Chief Medical Officer, Co-Founder
Scott Tomlins
Join now and verify your accreditation status to gain access to:
- Strata Oncology Current Valuation
- Strata Oncology Stock Price
- Strata Oncology Management
- Available deals in Strata Oncology and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Strata Oncology Cap Table and Funding History by Share Class and Liquidity Preferences
- Strata Oncology Revenue and Financials
- Strata Oncology Highlights
- Strata Oncology Business Model
- Strata Oncology Risk Factors
- Strata Oncology Research Report from SACRA Research
Trading Strata Oncology Stock
How to invest in Strata Oncology stock?
Accredited investors can buy pre-IPO stock in companies like Strata Oncology through EquityZen funds. These investments are made available by existing Strata Oncology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Strata Oncology stock?
Shareholders can sell their Strata Oncology stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
